Global Diabetic Neuropathy Treatment (Peripheral, Autonomic, NSAIDs, Capsaicin, Opioid) Market Size, Share & Trends Analysis Report 2024-2030
April 22, 2024 10:20 ET
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Global Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report by Disorder Type (Peripheral Neuropathy, Autonomic Neuropathy),...
Global Market for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders: 2022-23 Data, Forecasts for 2024- 2026 and CAGR Projections through 2028
December 22, 2023 05:03 ET
|
Research and Markets
Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders" report has been added to ResearchAndMarkets.com's offering. ...
Global Peripheral Neuropathy Market Report 2022: Strategic Insight and Analysis of Key Drivers, Market Factors & Players
October 25, 2022 06:33 ET
|
Research and Markets
Dublin, Oct. 25, 2022 (GLOBE NEWSWIRE) -- The "Peripheral Neuropathy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Chemotherapy Induced Peripheral Neuropathy Market 2028: Emerging Markets in Developing Countries Present Opportunities
July 14, 2022 06:33 ET
|
Research and Markets
Dublin, July 14, 2022 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class and Distribution Channel" report...